Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Human Life Cord Japan Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The profile identifies 1 distinct examiner and 1 distinct art unit. GRABER, JAMES J is the busiest examiner, with 1 pending matter. The prosecution activity shown is concentrated in one examination assignment involving the company’s biotechnology and pharmaceutical subject matter.
Counsel should respond to the action with a clear explanation of the claimed biological subject matter and its distinction from the cited art. Any amendment should be tested against the original disclosure and the desired claim scope. The single examiner and art-unit context allow the response to establish a consistent record that can guide further prosecution of the pending matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRABER, JAMES J | 1 | 46.5% | +57.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18043501 | CELL PREPARATION FOR USE IN SUPPRESSING MUSCLE MASS LOSS | GRABER, JAMES J | 37d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18043501 | CELL PREPARATION FOR USE IN SUPPRESSING MUSCLE MASS LOSS | GRABER, JAMES J | 37d overdue |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18043501 | CELL PREPARATION FOR USE IN SUPPRESSING MUSCLE MASS LOSS | GRABER, JAMES J | 1631 | §102§103 | Non-Final OA | 37d overdue | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHuman Life Cord Japan Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
James J Graber has the most, with 1 of Human Life Cord Japan Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
